% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Hermann:285159,
author = {Hermann, Wiebke and Sankutlu, Aleyna and Nabers, Lydia and
Sehr, Tony and Trentzsch, Katrin and Donix, Markus and
Reichmann, Heinz and Brandt, Daniel Moritz and Storch,
Alexander and Ziemssen, Tjalf},
title = {{G}ait dysfunction as an early marker of phenoconversion in
{REM} sleep behavior disorder.},
journal = {Scientific reports},
volume = {16},
number = {1},
issn = {2045-2322},
address = {[London]},
publisher = {Springer Nature},
reportid = {DZNE-2026-00181},
pages = {5614},
year = {2026},
abstract = {Clinical isolated REM Sleep Behavior Disorder (iRBD) is a
prodromal stage of α-synucleinopathies such as Parkinson's
disease (PD). Longitudinal changes of gait as a marker of
phenoconversion in iRBD have not been systematically
evaluated yet. Therefore, twenty-one iRBD patients, nineteen
matched healthy controls and fourteen PD patients $(H\&Y$
stage I - III) were assessed at baseline using a
pressure-sensor walkway (GAITRite). While normalized gait
velocity and walking endurance were significantly decreased
in iRBD patients compared to controls, gait rhythm
parameters such as single support further discriminated PD
from iRBD and controls. IRBD patients at imminent risk of
phenoconversion within the next 3.7 ± 0.6 years were
distinguishable from non-converters by gait rhythm
parameters such as single support. Since gait evaluation of
our iRBD cohort showed promising results in predicting
imminent phenoconversion, future multicenter trials should
include gait analysis as an objective assessment of motor
function to confirm our results.},
keywords = {Humans / REM Sleep Behavior Disorder: physiopathology / REM
Sleep Behavior Disorder: diagnosis / Male / Female / Middle
Aged / Parkinson Disease: physiopathology / Parkinson
Disease: diagnosis / Aged / Gait: physiology / Case-Control
Studies / Biomarkers / Gait Disorders, Neurologic:
physiopathology / Gait Disorders, Neurologic: diagnosis /
Gait dysfunction (Other) / Parkinson’s disease (Other) /
Progression (Other) / REM sleep behaviour disorder (Other) /
Α-synucleinopathies (Other) / Biomarkers (NLM Chemicals)},
cin = {AG Storch},
ddc = {600},
cid = {I:(DE-2719)5000014},
pnm = {353 - Clinical and Health Care Research (POF4-353)},
pid = {G:(DE-HGF)POF4-353},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:41663457},
doi = {10.1038/s41598-026-37925-w},
url = {https://pub.dzne.de/record/285159},
}